Biblio Discovery — Demo Discovery Service

23 results for "Johan Courjon"

Showing 1–20 · 1.09 seconds · RSS

  1. Journal Article

    Case Report: Autoimmune Hemolysis Anemia After Dihydroartemisinin and Piperaquine for Uncomplicated Plasmodium falciparum Malaria

    Marion Louvois; Loïc Simon; Christelle Pomares et al.

    Frontiers in Medicine, Vol. 8 · 2022 · English · DOAJ Scopus

    Malaria is still an endemic disease in Africa, with many imported cases in Europe. The standard treatment is intravenous artesunate for severe malaria and oral artemisinin-based combination therapy (ACT) for uncomplicated malaria. Delayed hemolytic anemia (DHA) after intravenous artesunate has been…

  2. Journal Article

    Patients with community-acquired bacteremia of unknown origin: clinical characteristics and usefulness of microbiological results for therapeutic issues: a single-center cohort study

    Johan Courjon; Elisa Demonchy; Nicolas Degand et al.

    Annals of Clinical Microbiology and Antimicrobials, Vol. 16 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Bacteremia of unknown origin (BUO) are associated with increased mortality compared to those with identified sources. Microbiological data of those patients could help to characterize an appropriate empirical antibiotic treatment before bloodcultures results are available during sepsis of…

  3. Journal Article

    Time-to-detection in culture of Mycobacterium tuberculosis: performance for assessing index cases contact-positivity

    Karine Risso; Céline Michelangeli; Alice Gaudart et al.

    International Journal of Infectious Diseases, Vol. 134 · 2023 · English · DOAJ Scopus

    Objectives: Time-to-detection (TTD) in culture on liquid media is inversely correlated to bacillary load and should be a contributing factor for assessing tuberculosis transmission. We wanted to assess if TTD was a better alternative than smear status to estimate transmission risk. Methods: From…

  4. Journal Article

    Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses

    Matthieu Buscot; Marion Cremoni; Daisy Graça et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    IntroductionCOVID-19 vaccines are expected to provide effective protection. However, emerging strains can cause breakthrough infection in vaccinated individuals. The immune response of vaccinated individuals who have experienced breakthrough infection is still poorly understood.MethodsHere, we…

  5. Journal Article

    Efficacy of an antimicrobial stewardship intervention for early adaptation of antibiotic therapy in high-risk neutropenic patients

    Claire Durand; Karine Risso; Michael Loschi et al.

    Antimicrobial Resistance and Infection Control, Vol. 13 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background The 4th European Conference on Infections in Leukemia recommends early adaptation of empirical antibiotic therapy (EAT) for febrile neutropenia in stable patients. Objectives To assess the efficacy of an antimicrobial stewardship (AMS) intervention promoting early de-escalation…

  6. Journal Article Full text

    What Place Is There for Long-Acting Antibiotics in the Management of Gram-Positive Infections? A Qualitative Cross-Sectional Study

    Aurélien Dinh; Guillaume Béraud; Johan Courjon et al.

    Antibiotics, Vol. 13 No. 7 · 2024 · English · DOAJ Scopus

    Objectives. To identify the current practices with long half-life lipoglycopeptides (LGPs) and potential use/position of oritavancin. Results. Despite their indication being limited to skin and soft tissue infections (SSTIs), long half-life lipoglycopeptides are mainly used off-label to treat bone…

  7. Journal Article Full text

    Clindamycin Efficacy for Cutibacterium acnes Shoulder Device-Related Infections

    Audrey Courdurié; Romain Lotte; Raymond Ruimy et al.

    Antibiotics, Vol. 11 No. 5 · 2022 · English · DOAJ Scopus

    Clindamycin is an antibiotic with high bioavailability and appropriate bone diffusion, often proposed as an alternative in guidelines for C. acnes prosthetic joint infections. We aimed to evaluate the efficacy of clindamycin in the treatment of C. acnes shoulder implant joint infections (SIJI)…

  8. Journal Article

    Management of prosthetic joint infections in France: a national audit to identify key situations requiring innovation and homogenization

    Marion Le Maréchal; Zoé Cavalli; Cécile Batailler et al.

    BMC Infectious Diseases, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Prosthetic joint infections (PJI) are one of the most serious complication of arthroplasty. The management of PJI needs a multidisciplinary collaboration between orthopaedic surgeon, infectious disease specialist and microbiologist. In France, the management of PJI is organized…

  9. Journal Article

    Proteinuria as a Biomarker for COVID-19 Severity

    Hajar Ouahmi; Johan Courjon; Lucas Morand et al.

    Frontiers in Physiology, Vol. 12 · 2021 · English · DOAJ Scopus

    BackgroundRenal involvement in syndrome coronavirus 2 (SARS-CoV-2) infection has been retrospectively described, especially acute kidney injury (AKI). However, quantitative proteinuria assessment and its implication in coronavirus disease 2019 (COVID-19) remain unknown.MethodsIn this prospective…

  10. Journal Article

    COVID-19 patients age, comorbidity profiles and clinical presentation related to the SARS-CoV-2 UK-variant spread in the Southeast of France

    Johan Courjon; Julie Contenti; Elisa Demonchy et al.

    Scientific Reports, Vol. 11 No. 1 · 2021 · English · DOAJ Scopus

    Abstract The variant 20I/501Y.V1, associated to a higher risk of transmissibility, emerged in Nice city (Southeast of France, French Riviera) during January 2021. The pandemic has resumed late December 2020 in this area. A high incidence rate together with a fast turn-over of the main circulating…

  11. Journal Article Full text

    Pyogenic vertebral osteomyelitis of the elderly: Characteristics and outcomes.

    Johan Courjon; Adrien Lemaignen; Idir Ghout et al.

    PLoS ONE, Vol. 12 No. 12 · 2017 · English · DOAJ Scopus

    The incidence of pyogenic vertebral osteomyelitis (PVO) has increased over the past two decades. One possible cause of this increase is the aging of the population, which results in more comorbidities in high income countries.To better characterize the clinical presentation and outcome of PVO in…

    Also available at: PLOS

  12. Journal Article Full text

    EDIN-B Promotes the Translocation of Staphylococcus aureus to the Bloodstream in the Course of Pneumonia

    Johan Courjon; Patrick Munro; Yvonne Benito et al.

    Toxins, Vol. 7 No. 10 · 2015 · English · DOAJ Scopus

    It is crucial to define risk factors that contribute to host invasion by Staphylococcus aureus. Here, we demonstrate that the chromosomally encoded EDIN-B isoform from S. aureus contributes to the onset of bacteremia during the course of pneumonia. Deletion of edinB in a European lineage…

  13. Journal Article

    Immunogenicity of PCV13 during Hospitalization soon after infection resolution: Vaccis study

    Julie Mérindol; Irit Touitou; Coralie Cruzel et al.

    npj Vaccines, Vol. 11 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Vaccination against Streptococcus pneumoniae in high-risk patients is crucial and hospitalization is a valuable opportunity. Adult patients hospitalized (>48 hours) for various infectious conditions and eligible for 13-valent pneumococcal conjugate vaccination from April 2021 to 2023 were…

  14. Journal Article

    Dalbavancin treatment for prosthetic joint infections in real-life: a national cohort study and literature review

    Morgan Matt; Clara Duran; Johan Courjon et al.

    Journal of Global Antimicrobial Resistance, Vol. 25 · 2021 · English · DOAJ Scopus

    ABSTRACT: Objectives: Dalbavancin is a long-lasting lipoglycopeptide active against Gram-positive bacteria, especially methicillin-resistant staphylococci. Few data are available on dalbavancin use for treatment of prosthetic joint infections (PJIs). We describe a cohort of patients treated for PJI…

  15. Journal Article

    Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients

    Caroline Ruetsch; Vesna Brglez; Marion Crémoni et al.

    Frontiers in Medicine, Vol. 7 · 2021 · English · DOAJ Scopus

    Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has emerged in Wuhan in December 2019 and has since spread across the world. Even though the majority of patients remain completely asymptomatic, some develop severe systemic complications. In…

  16. Journal Article Full text

    Efficacy and safety of anakinra in adults presenting deteriorating respiratory symptoms from COVID-19: A randomized controlled trial

    Alexandra Audemard-Verger; Amélie Le Gouge; Vincent Pestre et al.

    PLOS ONE, Vol. 17 No. 8 · 2022 · English · PLOS Scopus

    Objective: We aimed to investigate whether anakinra, an interleukin-1receptor inhibitor, could improve outcome in moderate COVID-19 patients. Methods: In this controlled, open-label trial, we enrolled adults with COVID-19 requiring oxygen. We randomly assigned patients to receive intravenous…

  17. Journal Article Full text

    Real-Life Cefiderocol Use in Bone and Joint Infection: A French National Cohort

    Ava Diarra; Maxime Degrendel; Isabelle Eberl et al.

    Antibiotics, Vol. 14 No. 4 · 2025 · English · DOAJ Scopus

    Background: Cefiderocol (CFD) is a novel siderophore cephalosporin developed for the treatment of infections involving multidrug-resistant (MDR) Gram-negative bacilli (GNB) infections (1–3). For bone and joint infections (BJIs), the use of CFD is currently neither part of its market authorization…